These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1108 related articles for article (PubMed ID: 8815006)

  • 1. Transcriptionally targeted gene therapy.
    Hart IR
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():19-25. PubMed ID: 8815006
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor necrosis factor alpha-mediated inhibition of melanogenesis is dependent on nuclear factor kappa B activation.
    Englaro W; Bahadoran P; Bertolotto C; Buscà R; Dérijard B; Livolsi A; Peyron JF; Ortonne JP; Ballotti R
    Oncogene; 1999 Feb; 18(8):1553-9. PubMed ID: 10102625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a melanogenesis regulation assay system using a fluorescent protein reporter combined with the promoters for the melanogenesis-related genes in human melanoma cells.
    Lin CC; Yang CH; Lin YJ; Chiu YW; Chen CY
    Enzyme Microb Technol; 2015 Jan; 68():1-9. PubMed ID: 25435499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane glycoproteins common to vesicles and melanosomes in mouse melanoma cells.
    Orlow SJ; Chakraborty AK; Pawelek JM
    Pigment Cell Res; 1992; Suppl 2():162-70. PubMed ID: 1384030
    [No Abstract]   [Full Text] [Related]  

  • 5. A post melanosomal era: control of melanogenesis and melanoma growth.
    Mishima Y
    Pigment Cell Res; 1992; Suppl 2():3-16. PubMed ID: 1409434
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormonal regulation of melanogenesis in mouse melanoma and in human melanocytes.
    Fuller BB; Rungta D; Iozumi K; Hoganson GE; Corn TD; Cao VA; Ramadan ST; Owens KC
    Ann N Y Acad Sci; 1993 May; 680():302-19. PubMed ID: 8512220
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of L-glutamine on tyrosinase and gamma-glutamyl transpeptidase of B-16 melanoma cells in culture.
    Chakraborty C; Hatta S; Ichihashi M; Hayashibe K; Mishima Y
    J Dermatol; 1988 Feb; 15(1):1-6. PubMed ID: 2899096
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in expression of putative antigens encoded by pigment genes in mouse melanomas at different stages of malignant progression.
    Orlow SJ; Hearing VJ; Sakai C; Urabe K; Zhou BK; Silvers WK; Mintz B
    Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10152-6. PubMed ID: 7479744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered N-glycosylation in macrophage x melanoma fusion hybrids.
    Pawelek JM; Chakraborty AK; Rachkovsky ML; Orlow SJ; Bolognia JL; Sodi SA
    Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1011-27. PubMed ID: 10644005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integumental pigmentary factors of lower vertebrates--models for human hypo- and hypermelanoses.
    Bagnara JT; Fukuzawa T; Johnson WC; Law JH; Samaraweera P; Zuasti A
    Pigment Cell Res; 1992; Suppl 2():254-61. PubMed ID: 1409427
    [No Abstract]   [Full Text] [Related]  

  • 11. Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma.
    Okada Y; Okada N; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T
    Cancer Gene Ther; 2005 Jul; 12(7):608-16. PubMed ID: 15746944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specific, cell cycle-regulated chimeric transcription factors for the targeting of gene expression to tumor cells.
    Jérôme V; Müller R
    Hum Gene Ther; 1998 Dec; 9(18):2653-9. PubMed ID: 9874263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted gene therapy.
    Hart IR; Vile RG
    Br Med Bull; 1995 Jul; 51(3):647-55. PubMed ID: 7552086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TFE3, a transcription factor homologous to microphthalmia, is a potential transcriptional activator of tyrosinase and TyrpI genes.
    Verastegui C; Bertolotto C; Bille K; Abbe P; Ortonne JP; Ballotti R
    Mol Endocrinol; 2000 Mar; 14(3):449-56. PubMed ID: 10707962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of anti-melanogenic natural compounds from Galega officinalis and further drug repositioning.
    Lee JS; Kim WS; Kim JJ; Chin YW; Jeong HC; Choi JS; Min HG; Cha HJ
    J Dermatol Sci; 2012 Jul; 67(1):61-3. PubMed ID: 22608214
    [No Abstract]   [Full Text] [Related]  

  • 16. Agerarin inhibits α-MSH-induced TYR gene transcription via STAT3 suppression independent of CREB-MITF pathway.
    Shin SY; Gil HN; Choi JH; Lim Y; Lee YH
    J Dermatol Sci; 2018 Jul; 91(1):107-110. PubMed ID: 29625721
    [No Abstract]   [Full Text] [Related]  

  • 17. Indomethacin inhibits melanogenesis via down-regulation of Mitf mRNA transcription.
    Sato K; Takei M; Iyota R; Muraoka Y; Nagashima M; Yoshimura Y
    Biosci Biotechnol Biochem; 2017 Dec; 81(12):2307-2313. PubMed ID: 29090638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects of intense pulsed light and 5-aminolevulinic acid on the cultured B16 marine melanoma cells].
    Chen P; Jiang X; Wei DP; Li L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Mar; 41(2):280-3. PubMed ID: 20506653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosinase expression and melanogenesis in melanotic and amelanotic B16 mouse melanoma cells.
    Burchill SA; Bennett DC; Holmes A; Thody AJ
    Pathobiology; 1991; 59(5):335-9. PubMed ID: 1910528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of melanogenesis in cultured human melanoma cells.
    Slominski A; Ermak G; Wortsman J
    In Vitro Cell Dev Biol Anim; 1999; 35(10):564-5. PubMed ID: 10614864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 56.